Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation ExpenseLeasesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - NetWages, Salaries and Other
Ratios

Orchestra BioMed Holdings (OBIO) Receivables - Net (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Receivables - Net for 4 consecutive years, with $95000.0 as the latest value for Q4 2025.

  • Quarterly Receivables - Net rose 3.26% to $95000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $95000.0 through Dec 2025, up 3.26% year-over-year, with the annual reading at $95000.0 for FY2025, 3.26% up from the prior year.
  • Receivables - Net for Q4 2025 was $95000.0 at Orchestra BioMed Holdings, up from $52000.0 in the prior quarter.
  • The five-year high for Receivables - Net was $171000.0 in Q2 2023, with the low at $52000.0 in Q3 2025.
  • Average Receivables - Net over 4 years is $92384.6, with a median of $89000.0 recorded in 2025.
  • The sharpest move saw Receivables - Net skyrocketed 33.72% in 2024, then crashed 54.78% in 2025.
  • Over 4 years, Receivables - Net stood at $96000.0 in 2022, then rose by 3.12% to $99000.0 in 2023, then decreased by 7.07% to $92000.0 in 2024, then grew by 3.26% to $95000.0 in 2025.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $95000.0, $52000.0, and $83000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.